advertisement
Wei W 10
Showing records 1 to 10 | Display all abstracts from Wei W100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Li G
Frontiers in pharmacology 2022; 13: 919688
100271 Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
Wang H; Zhang R
BMC Ophthalmology 2022; 22: 163
100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Wang N; Zhang Y
Frontiers in pharmacology 2022; 13: 919688
100271 Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
Wang Y
BMC Ophthalmology 2022; 22: 163
100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Wei W
Frontiers in pharmacology 2022; 13: 919688
100271 Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
Chen R; Liu Y
BMC Ophthalmology 2022; 22: 163
100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Lu H
Frontiers in pharmacology 2022; 13: 919688
100271 Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
Li Y
BMC Ophthalmology 2022; 22: 163
100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Zhai S; Zhang C
Frontiers in pharmacology 2022; 13: 919688
100271 Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
Wei W
BMC Ophthalmology 2022; 22: 163
